Hyperfine, Inc. HYPR Product — Cost of Goods Sold

Other product segments

Similar metrics at other companies

OMProduct — Cost of Goods Sold

$8.83M-19.7%

STIMProduct — Cost of Goods Sold

$2.86M-9.3%

LQD

LQDAProduct — Cost of Goods Sold

$11.08M—

FCELProduct — Cost of Goods Sold

$20.28M+24.7%

INVAProduct — Cost of Goods Sold

$15.61M+76.5%

ACLSProduct — Cost of Goods Sold

$105.74M+11.9%

Questions, answered.

What is Hyperfine, Inc.'s product — cost of goods sold?

Hyperfine, Inc. (HYPR) reported product — cost of goods sold of $1.65M in Q1 2026.

How has Hyperfine, Inc.'s product — cost of goods sold changed year-over-year?

Hyperfine, Inc.'s product — cost of goods sold increased by 67.1% year-over-year, from $985K to $1.65M.

What is the long-term trend for Hyperfine, Inc.'s product — cost of goods sold?

Over 4 years (2021 to 2025), Hyperfine, Inc.'s product — cost of goods sold has grown at a 29.3% compound annual growth rate (CAGR), from $2.06M to $5.76M.

What does product — cost of goods sold mean?

This metric captures the direct costs associated with manufacturing and delivering the company's medical devices, including materials, labor, and overhead directly attributable to production. It is a critical measure for assessing the manufacturing efficiency and direct profitability of the product segment. Monitoring this helps identify trends in production costs relative to revenue generation.